GLP-1s can deliver value to patients. But the fact that GLP-1s aren’t cost-effective at their current net prices can limit insurer coverage and prevent equitable access.
Related Posts
Retail is being unbundled — just like media was a decade ago. Amazon & Walmart’s homepages are dying. Learn how…
The U.S. Nuclear Regulatory Commission announced it is moving forward to advance new uses of factory-built microreactors for non-conventional nuclear…
Looking for help with today’s New York Times Wordle? Here are hints, clues and commentary to help you solve today’s…
What separates the standouts from the stalled? Here are the key steps to doing it right and the common traps…
New product eco-system from ELO Gaming also includes a standalone integrated hub running Android OS, and a precision controller.
The F1 Movie has had a great opening weekend, but will it be enough to encourage the streaming services to…
Two recent studies point to productivity gains, higher quality work, and yes, greater job satisfaction with the use of AI.
Emotionally safe partners are consistent in the security, validation and open-mindedness they offer. Here’s what emotional safety looks like behind…
Apple Watch’s Noise app is more than a decibel reader. It’s changing how we understand sound, health, and our daily…
Looking for help with today’s NYT Strands puzzle? Here’s an extra hint to help you uncover the right words, as…